Most women with osteoporosis know that Fosamax, Actonel, and Boniva are suppose to combat the weakening of their bones but now questions are begin raised as to if they’re really work, The New York Times reports.
A pattern seems to have emerged that causes the patients’ femurs to crack while they were standing or walking. This was preceded by weeks or months of pain and aching but when the women who complain of the pain had X-rays there was no evidence suggesting what would happen to them. Dr. Dean G. Lorich (New York-Presbyterian/Weill Cornell) published that he had 20 patients with this injury. Nineteen of them were on Fosamax for an average of 6.9 years.
New studies have asked this question: are the prescription drugs actually repressing natural growth? Bones are in a continuous process of dissolving old bone mass and rebuilding it with new material the question is this being hindered. Some studies even suggest that taking osteoporosis drugs becomes unnecessary after five years of taking it and some patients might even want to consider taking a break from the drugs.
When fractures do occur they tend to take more time to heal and a more intense treatment. This happening is rare and is only 5 or 6 percent of the 300,000 hip fractures a year in American adults.
All in all, according to Dr. Susan M. Ott, only women with at least a three percent chance of a fracture in the next 10 years should be on these drugs.
(Parker-Pope, New York Times, 7/15/18)